Noradrenergic dysfunction and antidepressant treatment response

Citation
H. Correa et al., Noradrenergic dysfunction and antidepressant treatment response, EUR NEUROPS, 11(2), 2001, pp. 163-168
Citations number
48
Categorie Soggetti
Neurosciences & Behavoir
Journal title
EUROPEAN NEUROPSYCHOPHARMACOLOGY
ISSN journal
0924977X → ACNP
Volume
11
Issue
2
Year of publication
2001
Pages
163 - 168
Database
ISI
SICI code
0924-977X(200104)11:2<163:NDAATR>2.0.ZU;2-C
Abstract
The purpose of this study was to investigate differences in outcome followi ng treatment with two different antidepressants in depressed patients accor ding to their pretreatment hormonal response to clonidine. In all, 62 drug- free DSM-IV recurrent major depressed patients and 20 normal controls were studied. Patients were subsequently treated for 4 weeks with fluoxetine (n= 28), or amitriptyline (n=33), and were then classified as responders or non responders according to their final Hamilton depression scale score. Compar ed to controls, depressed patients showed lower CU response to CLO (Delta G H) (P<0.0002). One control (5%) and 35 depressed patients (56%) had blunted <Delta>GHI values. The efficacy of the two antidepressants was not signifi cantly different: 15 patients responded to AMI (44%), seven patients respon ded to FLUOX (25%) (P>0.15). However, in the subgroup of patients with blun ted Delta GH levels, the rate of responders was higher for AMI (11/21) comp ared, to FLUOX (1/14) treated patients (P<0.01). These results suggest that in depressed patients a blunted GH It sponse to CLO could predict antidepr essant response. <(c)> 2001 Elsevier Science B.V. All rights reserved.